A key regulator of the balance of signals that activate effector mechanisms versus those that restrain them, β-arrestin 2 mediates the inhibition of natural killer cell cytotoxicity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katie Ris-Vicari
References
Bryceson, Y.T. & Long, E.O. Curr. Opin. Immunol. 20, 344–352 (2008).
Ravetch, J.V. & Lanier, L.L. Science 290, 84–89 (2000).
Long, E.O. Immunol. Rev. (in the press).
Yu, M.-C. et al. Nat. Immunol. 9, 898–907 (2008).
Burshtyn, D.N. et al. Immunity 4, 77–85 (1996).
Olcese, L. et al. J. Immunol. 156, 4531–4534 (1996).
Beebe, K.D. et al. Biochemistry 39, 13251–13260 (2000).
Hof, P. et al. Cell 92, 441–450 (1998).
Stebbins, C.S. et al. Mol. Cell. Biol. 23, 6291–6299 (2003).
DeWire, S.M. et al. Annu. Rev. Physiol. 69, 483–510 (2007).
Lowin-Kropf, B. et al. J. Immunol. 165, 1314–1321 (2000).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bryceson, Y., Ljunggren, HG. Arrestin NK cell cytotoxicity. Nat Immunol 9, 835–836 (2008). https://doi.org/10.1038/ni0808-835
Issue Date:
DOI: https://doi.org/10.1038/ni0808-835
